HEADER TRANSFERASE 28-AUG-15 5DGS TITLE CRYSTAL STRUCTURE OF HUMAN FPPS IN COMPLEX WITH THE MONOPHOSPHONATE TITLE 2 COMPOUND 15 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FARNESYL PYROPHOSPHATE SYNTHASE; COMPND 3 CHAIN: F; COMPND 4 FRAGMENT: UNP RESIDUES 72-419; COMPND 5 SYNONYM: FPS,(2E,6E)-FARNESYL DIPHOSPHATE SYNTHASE, COMPND 6 DIMETHYLALLYLTRANSTRANSFERASE,FARNESYL DIPHOSPHATE SYNTHASE, COMPND 7 GERANYLTRANSTRANSFERASE; COMPND 8 EC: 2.5.1.10,2.5.1.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FDPS, FPS, KIAA1293; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: TUNER; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS TRANSFERASE, ISOPRENE BIOSYNTHESIS, CHOLESTEROL BIOSYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR J.M.RONDEAU,E.BOURGIER,S.LEHMANN REVDAT 4 08-MAY-24 5DGS 1 REMARK REVDAT 3 29-NOV-17 5DGS 1 REMARK REVDAT 2 27-JUL-16 5DGS 1 JRNL REVDAT 1 13-JUL-16 5DGS 0 JRNL AUTH W.JAHNKE,G.BOLD,A.L.MARZINZIK,S.OFNER,X.PELLE,S.COTESTA, JRNL AUTH 2 E.BOURGIER,S.LEHMANN,C.HENRY,R.HEMMIG,F.STAUFFER, JRNL AUTH 3 J.C.HARTWIEG,J.R.GREEN,J.M.RONDEAU JRNL TITL A GENERAL STRATEGY FOR TARGETING DRUGS TO BONE. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 54 14575 2015 JRNL REFN ESSN 1521-3773 JRNL PMID 26457482 JRNL DOI 10.1002/ANIE.201507064 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.JAHNKE,J.M.RONDEAU,S.COTESTA,A.MARZINZIK,X.PELLE,M.GEISER, REMARK 1 AUTH 2 A.STRAUSS,M.GOTTE,F.BITSCH,R.HEMMIG,C.HENRY,S.LEHMANN, REMARK 1 AUTH 3 J.F.GLICKMAN,T.P.RODDY,S.J.STOUT,J.R.GREEN REMARK 1 TITL ALLOSTERIC NON-BISPHOSPHONATE FPPS INHIBITORS IDENTIFIED BY REMARK 1 TITL 2 FRAGMENT-BASED DISCOVERY. REMARK 1 REF NAT.CHEM.BIOL. V. 6 660 2010 REMARK 1 REFN ESSN 1552-4469 REMARK 1 PMID 20711197 REMARK 1 DOI 10.1038/NCHEMBIO.421 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.L.MARZINZIK,R.AMSTUTZ,G.BOLD,E.BOURGIER,S.COTESTA, REMARK 1 AUTH 2 J.F.GLICKMAN,M.GOTTE,C.HENRY,S.LEHMANN,J.C.HARTWIEG,S.OFNER, REMARK 1 AUTH 3 X.PELLE,T.P.RODDY,J.M.RONDEAU,F.STAUFFER,S.J.STOUT,A.WIDMER, REMARK 1 AUTH 4 J.ZIMMERMANN,T.ZOLLER,W.JAHNKE REMARK 1 TITL DISCOVERY OF NOVEL ALLOSTERIC NON-BISPHOSPHONATE INHIBITORS REMARK 1 TITL 2 OF FARNESYL PYROPHOSPHATE SYNTHASE BY INTEGRATED LEAD REMARK 1 TITL 3 FINDING. REMARK 1 REF CHEMMEDCHEM V. 10 1884 2015 REMARK 1 REFN ESSN 1860-7187 REMARK 1 PMID 26381451 REMARK 1 DOI 10.1002/CMDC.201500338 REMARK 2 REMARK 2 RESOLUTION. 2.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 14515 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1451 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.83 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.93 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2922 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2149 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2628 REMARK 3 BIN R VALUE (WORKING SET) : 0.2086 REMARK 3 BIN FREE R VALUE : 0.2739 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.06 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 294 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2774 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 48 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 70.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.64480 REMARK 3 B22 (A**2) : 1.64480 REMARK 3 B33 (A**2) : -3.28950 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.494 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.281 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.468 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.282 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2866 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3885 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1003 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 82 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 405 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2866 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 357 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3632 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.61 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.33 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { F|* } REMARK 3 ORIGIN FOR THE GROUP (A): 10.1454 79.8974 26.6041 REMARK 3 T TENSOR REMARK 3 T11: -0.3369 T22: -0.3439 REMARK 3 T33: 0.3978 T12: -0.0222 REMARK 3 T13: 0.0063 T23: 0.0476 REMARK 3 L TENSOR REMARK 3 L11: 3.5057 L22: 2.0897 REMARK 3 L33: 2.1245 L12: 0.7786 REMARK 3 L13: -1.7105 L23: -0.7591 REMARK 3 S TENSOR REMARK 3 S11: -0.1355 S12: -0.1827 S13: -0.5451 REMARK 3 S21: 0.0245 S22: 0.0196 S23: 0.2071 REMARK 3 S31: 0.1924 S32: -0.0266 S33: 0.1159 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5DGS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1000213179. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS NOVEMBER 2005 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK AUGUST 2005 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14536 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.620 REMARK 200 RESOLUTION RANGE LOW (A) : 78.460 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 13.80 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 13.80 REMARK 200 R MERGE FOR SHELL (I) : 0.53700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.570 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX 2002 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2M SODIUM POTASSIUM PHOSPHATE, 25% REMARK 280 GLYCEROL, PH 4.7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.38600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.48100 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.48100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.69300 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.48100 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.48100 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 56.07900 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.48100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.48100 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 18.69300 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.48100 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.48100 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 56.07900 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 37.38600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 110.96200 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 110.96200 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 37.38600 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY F 4 REMARK 465 PRO F 5 REMARK 465 ASN F 6 REMARK 465 SER F 7 REMARK 465 ARG F 351 REMARK 465 ARG F 352 REMARK 465 LYS F 353 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN F 77 61.24 -106.34 REMARK 500 VAL F 124 -77.67 -85.92 REMARK 500 ALA F 178 78.99 -117.00 REMARK 500 LEU F 248 -76.66 -83.15 REMARK 500 ASN F 265 16.07 56.13 REMARK 500 LYS F 293 47.36 -80.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5A7 F 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5DGM RELATED DB: PDB REMARK 900 5DGM IS THE FPPS COMPLEX WITH THE MONOPHOSPHONATE COMPOUND 7 REMARK 900 RELATED ID: 5DGN RELATED DB: PDB REMARK 900 5DGN IS THE FPPS COMPLEX WITH COMPOUND 13 DBREF 5DGS F 6 353 UNP P14324 FPPS_HUMAN 72 419 SEQADV 5DGS GLY F 4 UNP P14324 EXPRESSION TAG SEQADV 5DGS PRO F 5 UNP P14324 EXPRESSION TAG SEQRES 1 F 350 GLY PRO ASN SER ASP VAL TYR ALA GLN GLU LYS GLN ASP SEQRES 2 F 350 PHE VAL GLN HIS PHE SER GLN ILE VAL ARG VAL LEU THR SEQRES 3 F 350 GLU ASP GLU MET GLY HIS PRO GLU ILE GLY ASP ALA ILE SEQRES 4 F 350 ALA ARG LEU LYS GLU VAL LEU GLU TYR ASN ALA ILE GLY SEQRES 5 F 350 GLY LYS TYR ASN ARG GLY LEU THR VAL VAL VAL ALA PHE SEQRES 6 F 350 ARG GLU LEU VAL GLU PRO ARG LYS GLN ASP ALA ASP SER SEQRES 7 F 350 LEU GLN ARG ALA TRP THR VAL GLY TRP CYS VAL GLU LEU SEQRES 8 F 350 LEU GLN ALA PHE PHE LEU VAL ALA ASP ASP ILE MET ASP SEQRES 9 F 350 SER SER LEU THR ARG ARG GLY GLN ILE CYS TRP TYR GLN SEQRES 10 F 350 LYS PRO GLY VAL GLY LEU ASP ALA ILE ASN ASP ALA ASN SEQRES 11 F 350 LEU LEU GLU ALA CYS ILE TYR ARG LEU LEU LYS LEU TYR SEQRES 12 F 350 CYS ARG GLU GLN PRO TYR TYR LEU ASN LEU ILE GLU LEU SEQRES 13 F 350 PHE LEU GLN SER SER TYR GLN THR GLU ILE GLY GLN THR SEQRES 14 F 350 LEU ASP LEU LEU THR ALA PRO GLN GLY ASN VAL ASP LEU SEQRES 15 F 350 VAL ARG PHE THR GLU LYS ARG TYR LYS SER ILE VAL LYS SEQRES 16 F 350 TYR LYS THR ALA PHE TYR SER PHE TYR LEU PRO ILE ALA SEQRES 17 F 350 ALA ALA MET TYR MET ALA GLY ILE ASP GLY GLU LYS GLU SEQRES 18 F 350 HIS ALA ASN ALA LYS LYS ILE LEU LEU GLU MET GLY GLU SEQRES 19 F 350 PHE PHE GLN ILE GLN ASP ASP TYR LEU ASP LEU PHE GLY SEQRES 20 F 350 ASP PRO SER VAL THR GLY LYS ILE GLY THR ASP ILE GLN SEQRES 21 F 350 ASP ASN LYS CYS SER TRP LEU VAL VAL GLN CYS LEU GLN SEQRES 22 F 350 ARG ALA THR PRO GLU GLN TYR GLN ILE LEU LYS GLU ASN SEQRES 23 F 350 TYR GLY GLN LYS GLU ALA GLU LYS VAL ALA ARG VAL LYS SEQRES 24 F 350 ALA LEU TYR GLU GLU LEU ASP LEU PRO ALA VAL PHE LEU SEQRES 25 F 350 GLN TYR GLU GLU ASP SER TYR SER HIS ILE MET ALA LEU SEQRES 26 F 350 ILE GLU GLN TYR ALA ALA PRO LEU PRO PRO ALA VAL PHE SEQRES 27 F 350 LEU GLY LEU ALA ARG LYS ILE TYR LYS ARG ARG LYS HET 5A7 F 401 30 HETNAM 5A7 {(E)-2-[6-(ACETYLAMINO)-8-(NAPHTHALEN-1-YL)QUINOLIN-2- HETNAM 2 5A7 YL]ETHENYL}PHOSPHONIC ACID FORMUL 2 5A7 C23 H19 N2 O4 P FORMUL 3 HOH *48(H2 O) HELIX 1 AA1 ASP F 8 THR F 29 1 22 HELIX 2 AA2 GLU F 30 HIS F 35 1 6 HELIX 3 AA3 ILE F 38 ALA F 53 1 16 HELIX 4 AA4 TYR F 58 VAL F 72 1 15 HELIX 5 AA5 GLU F 73 GLN F 77 5 5 HELIX 6 AA6 ASP F 78 ASP F 107 1 30 HELIX 7 AA7 TRP F 118 LYS F 121 5 4 HELIX 8 AA8 VAL F 124 LEU F 126 5 3 HELIX 9 AA9 ASP F 127 ARG F 148 1 22 HELIX 10 AB1 TYR F 152 ALA F 178 1 27 HELIX 11 AB2 THR F 189 THR F 201 1 13 HELIX 12 AB3 THR F 201 ALA F 217 1 17 HELIX 13 AB4 GLY F 221 PHE F 249 1 29 HELIX 14 AB5 ASP F 251 GLY F 256 1 6 HELIX 15 AB6 SER F 268 ARG F 277 1 10 HELIX 16 AB7 THR F 279 TYR F 290 1 12 HELIX 17 AB8 GLU F 294 LEU F 308 1 15 HELIX 18 AB9 ASP F 309 ALA F 333 1 25 HELIX 19 AC1 PRO F 338 TYR F 349 1 12 SHEET 1 AA1 2 THR F 111 ARG F 112 0 SHEET 2 AA1 2 GLN F 115 ILE F 116 -1 O GLN F 115 N ARG F 112 CISPEP 1 ALA F 334 PRO F 335 0 3.65 SITE 1 AC1 19 TYR F 10 GLY F 56 LYS F 57 TYR F 58 SITE 2 AC1 19 ASN F 59 ARG F 60 THR F 63 GLN F 96 SITE 3 AC1 19 ARG F 113 SER F 205 PHE F 206 PHE F 239 SITE 4 AC1 19 GLN F 242 LEU F 344 LYS F 347 ILE F 348 SITE 5 AC1 19 LYS F 350 HOH F 503 HOH F 512 CRYST1 110.962 110.962 74.772 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009012 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009012 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013374 0.00000